VALESOR is structured around 7 scientific Work Packages which have all started.
WP1 has defined the environmental stressors of main concern for the VALESOR tool by screening available information and identifying ongoing EU environmental policy processes. It has reviewed the last 10-20 years of epidemiology, toxicology, health impact assessments and economic valuation studies on environmental stressors. Moreover, it is identifying gaps in the literature.
So far, environmental stressors have been identified and literature reviews have been performed. 3 policy briefs and gap analysis are finalised.
WP2 intends to identify health impacts linked to chemical and pollutant exposures, develop response models and tools, accounting for multi-media exposure where appropriate, provide guidance on uncertainties in assessment, provide interpretation of impacts to enable robust linkage to valuation and policy appraisal.
So far, health impacts linked to chemical and pollutants exposures have been identified.
WP3 first estimates the WTP for health improvements that are robust to the modelling uncertainty inherent in a QALY, while remaining consistent within a VSL Life framework. It also estimates the impact for single and multi-chemical exposure on the VSC and on the WTP for health improvements for key health endpoints. WP3 also assesses the equity impacts from mortality and morbidity impacts for policy valuation, via a social welfare function approach. WP3 improves the complementarity of economic values by scoping available Cost-of-illness studies and construct a benefit-transfer methodology as well.
So far, the two survey instruments on WTP are still under construction and first results will be obtained after studies implementation. A report on social welfare functions is also being drafted.
WP4 creates step-by-step guidelines for valuation of health endpoints and to model development, based methodological developments on input data results of WP1–WP3 and aimed to the software tool developed in WP5. It also provides input exposure data for the modelling exercises and develops a guidance to policy makers (WP6).
Preliminary discussions have started about the guidelines for valuation of health endpoints and to model development.
WP5 develops an increased-complexity pollution valuation model (ARP v2.0) by including more environmental stressors (including chemicals) and allows for a larger set of economic and ethical perspectives to be represented. Based on ARP v2.0 model, WP5 will create a user-friendly website VALESOR valuation tool for policy makers. WP5 will publish and advertise both ARP v2.0 model and VALESOR tool
Work has been initiated to design new ARP model.
WP6 focuses on getting expert and stakeholder input to the new ARP model and VALESOR website tool development as well as training informing stakeholders and main target groups about the models’ and tools’ suitable uses.
So far, expert roster has been defined. Participation to EAERE conference on 3rd July 2024 & SBCA conference 19-20 September 2024 is planned.
WP7 will test the VALESOR outputs (guidance documents, ARP v2.0 model and VALESOR website tool) on real-word cases studies including sensitivity analysis. WP7 will also exchange lessons learned in outreach activities to disseminate experiences and empower decision-makers by demonstrating the added value of the VALESOR methodology and promote its wider acceptance among the public and the scientific community.
Selection of cases studies is done but related deliverable is due later.